Operating
Operating Cash Flow
Veradermics Operating Cash Flow decreased by 59.0% to -$21.17M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 59.0%, from -$13.32M to -$21.17M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalHigher is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026May 12, 2026
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
Metric ID:
net_cash_from_operatingHistorical Data
6 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | -$5.92M | -$5.92M | -$5.92M | -$5.92M | -$13.32M | -$21.17M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -124.9% | -59.0% |
| YoY Change | — | — | — | — | -124.9% | -59.0% |
Range-$21.17M – -$5.92M
CAGR+177.1%
Avg YoY Growth-91.9%
Median YoY Growth-91.9%
Current Streak2 quarters decline
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Veradermics 's operating cash flow?
- Veradermics (MANE) reported operating cash flow of -$21.17M in Q1 2026.
- How has Veradermics 's operating cash flow changed year-over-year?
- Veradermics 's operating cash flow decreased by 59.0% year-over-year, from -$13.32M to -$21.17M.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.